Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 16S ribosomal RNA (rRNA) decoding region, specifically the aminoacyl-tRNA binding site (A-site), is a fundamental component of the 30S ribosomal subunit essential for translational fidelity [Vicens, Q., & Westhof, E. (2001). Structure]. During protein synthesis, this region monitors the complementarity between the mRNA codon and the tRNA anticodon, ensuring that the correct amino acid is added to the growing polypeptide chain [Ogle, J. M., et al. (2001). Science]. When a cognate tRNA binds, highly conserved adenine residues (A1492 and A1493) undergo a conformational change, flipping out of the helix to stabilize the codon-anticodon interaction [Carter, A. P., et al. (2000). Nature]. This site is the primary pharmacological target for aminoglycoside antibiotics, which bind with high affinity to the internal loop of the A-site, forcing the adenine residues into the "on" state regardless of codon-anticodon match [Magnet, S., & Blanchard, J. S. (2005). Chemical Reviews]. This interference leads to significant mistranslation and the production of non-functional or toxic proteins, which eventually causes bacterial cell death [Kohanski, M. A., et al. (2007). Cell]. Resistance to drugs targeting this region often arises through enzymatic modification of the rRNA, such as methylation by 16S rRNA methyltransferases, or mutations that alter the binding pocket [Doi, Y., et al. (2016). Clinical Microbiology Reviews].
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in residues A1492 and A1493 that mimics cognate tRNA binding, leading to mistranslation and protein synthesis inhibition [Magnet, S., & Blanchard, J. S. (2005). Chemical Reviews]. Tetracyclines bind to the 30S subunit to sterically block the entry of aminoacyl-tRNA into the A-site [Carter, A. P., et al. (2000). Nature].
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 16S ribosomal RNA decoding site (16S rRNA A-site).